Stay updated on Apremilast-Dupilumab Combo in Eczema Clinical Trial

Sign up to get notified when there's something new on the Apremilast-Dupilumab Combo in Eczema Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Apremilast-Dupilumab Combo in Eczema Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added a dedicated Locations section featuring Massachusetts (Boston, MA) as a study location and removed the prior Massachusetts Locations entry; the page revision was updated from v3.3.2 to v3.3.3, and the HHS Vulnerability Disclosure link in the footer was removed.
    Difference
    0.2%
    Check dated 2025-12-23T09:13:44.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.2.0 on the page. It is a minor site update and does not modify study details or user actions.
    Difference
    0.1%
    Check dated 2025-11-24T18:20:14.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Removed the banner noting a lapse in government funding and related operating status; the page no longer displays that notice.
    Difference
    0.4%
    Check dated 2025-11-17T17:57:47.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page; the study details and content remain unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T12:38:10.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    - Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-05T17:34:27.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.
    Difference
    0.1%
    Check dated 2025-09-28T10:46:18.000Z thumbnail image

Stay in the know with updates to Apremilast-Dupilumab Combo in Eczema Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Apremilast-Dupilumab Combo in Eczema Clinical Trial page.